Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
| $1.92M | ﹤0.01% |
37,682
+1,932
| +5% | +$98.7K |
|
3002
Limoneira
LMNR
$251M
| $1.92M | ﹤0.01% |
109,197
-797
| -0.7% | -$14.6K |
|
|
TCRR
3003
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.9M | ﹤0.01% |
115,892
-9,188
| -7% | -$186K |
|
3004
Nathan's Famous
NATH
$398M
| $1.9M | ﹤0.01% |
26,648
-1,148
| -4% | -$76.5K |
|
3005
Annovis Bio
ANVS
$78.3M
| $1.9M | ﹤0.01% |
+22,168
| New | +$1.02M |
|
|
ISEE
3006
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.9M | ﹤0.01% |
300,307
-42,581
| -12% | -$275K |
|
3007
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.3B
| $1.89M | ﹤0.01% |
74,073
+5,041
| +7% | +$127K |
|
3008
Global Water Resources
GWRS
$249M
| $1.89M | ﹤0.01% |
110,418
-30,959
| -22% | -$525K |
|
|
CIXX
3009
DELISTED
CI Financial Corp.
CIXX
| $1.89M | ﹤0.01% |
102,588
+13,780
| +16% | +$236K |
|
3010
Applovin
APP
$106B
| $1.88M | ﹤0.01% |
+25,036
| New | +$1.73M |
|
3011
Eldorado Gold
EGO
$10.3B
| $1.88M | ﹤0.01% |
188,497
+115,609
| +159% | +$1.29M |
|
3012
HSBC
HSBC
$356B
| $1.87M | ﹤0.01% |
64,922
+3,777
| +6% | +$115K |
|
|
DX
3013
Dynex Capital
DX
$3.24B
| $1.87M | ﹤0.01% |
100,330
+6,982
| +7% | +$137K |
|
3014
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.07B
| $1.87M | ﹤0.01% |
64,760
+4,714
| +8% | +$135K |
|
3015
Aviat Networks
AVNW
$285M
| $1.87M | ﹤0.01% |
57,116
+25,966
| +83% | +$904K |
|
3016
VanEck Long Muni ETF
MLN
$681M
| $1.87M | ﹤0.01% |
85,373
-26,104
| -23% | -$567K |
|
3017
Precision BioSciences
DTIL
$205M
| $1.87M | ﹤0.01% |
4,975
-824
| -14% | -$247K |
|
3018
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.07B
| $1.87M | ﹤0.01% |
69,608
+4,425
| +7% | +$117K |
|
3019
WisdomTree Japan SmallCap Dividend Fund
DFJ
$407M
| $1.86M | ﹤0.01% |
25,228
+6,330
| +33% | +$478K |
|
|
GAN
3020
DELISTED
GAN Ltd
GAN
| $1.86M | ﹤0.01% |
112,933
+41,802
| +59% | +$737K |
|
|
XENT
3021
DELISTED
Intersect ENT, Inc
XENT
| $1.86M | ﹤0.01% |
108,622
-22,000
| -17% | -$412K |
|
|
CTLP
3022
DELISTED
Cantaloupe
CTLP
| $1.85M | ﹤0.01% |
155,968
+128,822
| +475% | +$1.51M |
|
3023
Tidewater
TDW
$4.72B
| $1.85M | ﹤0.01% |
153,446
-3,343
| -2% | -$44.4K |
|
3024
Lindblad Expeditions
LIND
$2.19B
| $1.85M | ﹤0.01% |
115,285
-6,140
| -5% | -$104K |
|
3025
iShares Agency Bond ETF
AGZ
$565M
| $1.84M | ﹤0.01% |
15,586
+2,559
| +20% | +$302K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.